You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 7, 2025

Drug Price Trends for NDC 68462-0228


✉ Email this page to a colleague

« Back to Dashboard


Best Wholesale Price for NDC 68462-0228

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Dates Price Type
LAMOTRIGINE 5MG TAB,CHEW Golden State Medical Supply, Inc. 68462-0228-01 100 39.76 0.39760 2023-06-15 - 2028-06-14 FSS
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

68462-0228 Market Analysis and Financial Projection

Market Analysis and Price Projections for the Drug NDC: 68462-0228

Introduction

The pharmaceutical market is a complex and dynamic sector, influenced by various factors including regulatory changes, technological advancements, and market demand. This article will focus on the market analysis and price projections for a specific drug identified by the National Drug Code (NDC) 68462-0228, although the specific drug details for this NDC are not provided in the sources. We will use general trends and data from similar pharmaceutical products to provide insights.

Pharmaceutical Market Overview

The US pharmaceutical market is one of the largest and most influential globally, projected to grow from $846.72 billion in 2022 to $1.28 trillion by 2030, with a Compound Annual Growth Rate (CAGR) of 5.36%[4].

Market Segments and Growth Drivers

The market is segmented into vaccines, biologics & biosimilars, and small molecules. The small molecules segment, which includes generic and branded drugs, held the largest market share in 2022. However, the biologics & biosimilars segment is expected to register the highest CAGR during the forecast period[4].

Impact of Technological Advancements

Technological advancements, particularly the adoption of AI-based tools for drug discovery, are driving growth in the pharmaceutical market. Companies like Janssen, Bayer, and GlaxoSmithKline are leveraging AI to streamline the identification of novel biological targets and optimize drug candidates[4].

Regulatory Landscape

The regulatory landscape is evolving to keep pace with innovation. In 2025, clinical trial designs are expected to become more innovative and efficient, focusing on patient-centered care and reducing the time and cost associated with traditional trials[3].

Price Trends and Transparency

Drug prices can be highly volatile. For instance, a generic version of naproxen saw a 2,527% price increase between 2012 and 2021, highlighting the significant variability in drug pricing[2].

Specific Drug Pricing Analysis

For the drug with NDC 68462-0228, without specific details, we can look at similar drugs for insights. For example, Abiraterone Acetate (NDC 68462-0135), a drug used in the treatment of prostate cancer, has seen price fluctuations. The average pharmacy cost for Abiraterone Acetate 250 MG TAB has ranged from $0.98375 to $1.08623 per unit over recent months[1].

Factors Influencing Drug Prices

Several factors influence drug prices, including:

  • Production Costs: The cost of raw materials, manufacturing, and distribution.
  • Regulatory Approvals: The time and cost associated with obtaining regulatory approvals.
  • Market Demand: The demand for the drug, which can be influenced by the prevalence of the condition it treats.
  • Competition: The presence of generic or biosimilar alternatives.
  • Research and Development (R&D) Investments: Significant R&D expenditures can impact pricing to ensure profitability[4].

Price Projections

Given the lack of specific data for NDC 68462-0228, we can infer from broader market trends:

  • Generic Drugs: Median price increases for generic drugs have been around 19.9% in recent years. If the drug in question is a generic, it might follow similar trends[2].
  • Brand Name Drugs: For brand name drugs, the median price increase is typically lower, around 13.4%[2].

Conclusion

The pharmaceutical market is poised for significant growth driven by technological advancements, evolving regulatory frameworks, and increasing demand. While specific price projections for NDC 68462-0228 cannot be made without detailed data, understanding broader market trends and factors influencing drug prices can provide valuable insights.

Key Takeaways

  • The US pharmaceutical market is projected to grow significantly by 2030.
  • Technological advancements, such as AI in drug discovery, are key growth drivers.
  • Regulatory changes are shifting towards more efficient and patient-centered clinical trials.
  • Drug prices are influenced by production costs, regulatory approvals, market demand, competition, and R&D investments.
  • Generic and brand name drugs have different price increase trends.

FAQs

Q: What is the projected growth rate of the US pharmaceutical market? A: The US pharmaceutical market is projected to grow at a CAGR of 5.36% from 2022 to 2030[4].

Q: How are technological advancements impacting the pharmaceutical market? A: Technological advancements, particularly the adoption of AI-based tools, are accelerating drug discovery and development processes[4].

Q: What are the main segments of the pharmaceutical market? A: The main segments include vaccines, biologics & biosimilars, and small molecules (generic and branded)[4].

Q: Why do drug prices fluctuate significantly? A: Drug prices can fluctuate due to factors such as production costs, regulatory approvals, market demand, competition, and R&D investments[2][4].

Q: How are regulatory changes affecting clinical trials? A: Regulatory changes are leading to more innovative and efficient clinical trial designs, focusing on patient-centered care and reducing timelines[3].

Sources

  1. DrugPatentWatch - Latest drug prices and trends for NDC 68462-0135.
  2. Oregon Department of Consumer and Business Services - Prescription Drug Price Transparency Results and Recommendations.
  3. TFS CRO - 5 Predictions for the Biopharma and Biotech Industries in 2025.
  4. GlobeNewswire - US Pharmaceutical Market Review 2020-2023 and Forecast 2024-2030.
  5. FDA.report - NDC 68462-162 Oral Tablet, Film Coated Carvedilol.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.